Subclinical cardiovascular disease parameters after one year in new users of depot medroxyprogesterone acetate compared to copper-IUD.

Kleber CursinoGabriel Araújo de LimaPriscilla de Nazaré Silva Dos SantosElizabeth João PavinLuis BahamondesArlete Maria Fernandes

Published in: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (2018)

No clinical cardiovascular effect was found but deterioration in CV markers was observed in the first year of use of DMPA.

Keyphrases

cardiovascular disease
cardiovascular risk factors
metabolic syndrome